Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts
European Respiratory Journal · 2024-02 · 63 (2) · 2301326
DOI: 10.1183/13993003.01326-2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 11.01.2024. Verfasst von Christoph H Mayr und 32 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Pneumology Center (CPC)/Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Member of the German Center for Lung Research (D…. Hauptthemen laut MEDLINE: Myofibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Chan Zuckerberg Initiative.
Abstract (Originalsprache)
Background
Fibroblast-to-myofibroblast conversion is a major driver of tissue remodelling in organ fibrosis. Distinct lineages of fibroblasts support homeostatic tissue niche functions, yet their specific activation states and phenotypic trajectories during injury and repair have remained unclear.
Methods
We combined spatial transcriptomics, multiplexed immunostainings, longitudinal single-cell RNA-sequencing and genetic lineage tracing to study fibroblast fates during mouse lung regeneration. Our findings were validated in idiopathic pulmonary fibrosis patient tissues in situ as well as in cell differentiation and invasion assays using patient lung fibroblasts. Cell differentiation and invasion assays established a function of SFRP1 in regulating human lung fibroblast invasion in response to transforming growth factor (TGF)β1. Measurements and main results We discovered a transitional fibroblast state characterised by high Sfrp1 expression, derived from both Tcf21 -Cre lineage positive and negative cells. Sfrp1 + cells appeared early after injury in peribronchiolar, adventitial and alveolar locations and preceded the emergence of myofibroblasts. We identified lineage-specific paracrine signals and inferred converging transcriptional trajectories towards Sfrp1 + transitional fibroblasts and Cthrc1 + myofibroblasts. TGFβ1 downregulated SFRP1 in noninvasive transitional cells and induced their switch to an invasive CTHRC1 + myofibroblast identity. Finally, using loss-of-function studies we showed that SFRP1 modulates TGFβ1-induced fibroblast invasion and RHOA pathway activity.
Conclusions
Our study reveals the convergence of spatially and transcriptionally distinct fibroblast lineages into transcriptionally uniform myofibroblasts and identifies SFRP1 as a modulator of TGFβ1-driven fibroblast phenotypes in fibrogenesis. These findings are relevant in the context of therapeutic interventions that aim at limiting or reversing fibroblast foci formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Comprehensive Pneumology Center (CPC)/Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
- C.H. Mayr and A. Sengupta contributed equally to this work.
- Institute of Computational Biology, Helmholtz Munich, Munich, Germany.
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
- SciLifeLab, Stockholm, Sweden.
- Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany.
ORCID-Profile: Ilias Angelidis, Andreas Liontos, Michael Gerckens, Laurens J De Sadeleer, Martin Irmler, Nikolaus Kneidinger, Wim A Wuyts, Roxana Maria Wasnick, Ali Önder Yildirim, Rory E Morty
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- Chan Zuckerberg Initiative
- European Union’s Horizon 2020 research and innovation program
Zitieren
APA
Mayr, C. H., Sengupta, A., Asgharpour, S., Ansari, M., Pestoni, J. C., Ogar, P., Angelidis, I., Liontos, A., Rodriguez-Castillo, J. A., Lang, N. J., Strunz, M., Porras-Gonzalez, D., Gerckens, M., De Sadeleer, L. J., Oehrle, B., Viteri-Alvarez, V., Fernandez, I. E., Tallquist, M., Irmler, M., …, & Schiller, H. B. (2024). Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts. European Respiratory Journal, 63(2), 2301326. https://doi.org/10.1183/13993003.01326-2023
Vancouver
Mayr CH, Sengupta A, Asgharpour S, Ansari M, Pestoni JC, Ogar P, et al. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts. European Respiratory Journal. 2024;63(2):2301326. doi:10.1183/13993003.01326-2023
BibTeX
@article{Mayr2024,
author = {Mayr, Christoph H and Sengupta, Arunima and Asgharpour, Sara and Ansari, Meshal and Pestoni, Jeanine C and Ogar, Paulina and Angelidis, Ilias and Liontos, Andreas and Rodriguez-Castillo, José Alberto and Lang, Niklas J and Strunz, Maximilian and Porras-Gonzalez, Diana and Gerckens, Michael and De Sadeleer, Laurens J and Oehrle, Bettina and Viteri-Alvarez, Valeria and Fernandez, Isis E and Tallquist, Michelle and Irmler, Martin and Beckers, Johannes and Eickelberg, Oliver and Stoleriu, Gabriel Mircea and Behr, Jürgen and Kneidinger, Nikolaus and Wuyts, Wim A and Wasnick, Roxana Maria and Yildirim, Ali Önder and Ahlbrecht, Katrin and Morty, Rory E and Samakovlis, Christos and Theis, Fabian J and Burgstaller, Gerald and Schiller, Herbert B},
title = {Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts},
journal = {European Respiratory Journal},
year = {2024},
volume = {63},
number = {2},
pages = {2301326},
doi = {10.1183/13993003.01326-2023}
}
EUVIMED